BackApexigen- Warrants (29/07/2027) Overview
Apexigen Inc - Warrants (29/07/2027)

Apexigen- Warrants (29/07/2027) Return on Equity

Apexigen- Warrants (29/07/2027) (APGNW) has a ROE of 1148.14%, above the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

1148.14%

Return on Equity

1148.14%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Apexigen- Warrants (29/07/2027) (APGNW) FAQ

Apexigen- Warrants (29/07/2027)'s return on equity stands at 1148.14%. That is above the sector sector average of -5.87%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Apexigen- Warrants (29/07/2027) sits higher the its sector benchmark (-5.87%) with a ROE of 1148.14%. That is roughly 19664.4% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 1148.14% for Apexigen- Warrants (29/07/2027) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Apexigen- Warrants (29/07/2027)'s ROE evolved across reporting periods, while the comparison chart places APGNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.